Skip to main content

GKOS Glaukos Corporation

Healthcare

238.61 +1.01 +0.43% Close 11/2
Since 2024-12-02 +70.8%
Open
235.00
High
243.74
Low
232.29
Prev close
237.60
Volume
1.6M
Amplitude
4.82%
P/B
19.6
Revenue YoY (TTM)
+46.9%
52W 80.91 248.75

Is Glaukos Corporation a buy? Fundamentals and valuation first

As of 2026-10-30

Growth: Strong, Momentum: Strong; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Average; Price / book is Expensive.
TTM P/E -80.82 N/A
Price / book 19.61 96th percentile Expensive
Free-cash-flow yield (%) 0.26 49th percentile Average
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Neutral FCF margin, TTM is Good, but ROE, TTM is Average.
ROE, TTM (%) -23.67 24th percentile Average
Operating margin, TTM (%) -9.17 27th percentile Average
FCF margin, TTM (%) 5.22 52th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Strong All 2 indicators are Top.
Revenue growth, TTM YoY (%) 46.94 86th percentile Top
Diluted EPS growth, TTM YoY (%) 90.91 83th percentile Top
Momentum Strong All 2 indicators are Top.
60-day return (%) 38.96 97th percentile Top
240-day return (%) 163.91 98th percentile Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Neutral 20-day dollar volume is Top, but 60-day annualized volatility is Average.
20-day dollar volume 257,982,118 94th percentile Top
60-day annualized volatility (%) 78.45 75th percentile Average
Factor Investing Explained: 10 Classic Factors in US Stocks

Glaukos Corporation (GKOS) today

4 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Glaukos Corporation to every stock like it

AI finds several complementary traits of Glaukos Corporation across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Glaukos Corporation

Glaukos Corporation (GKOS) peers and tracking

Watchlist

This page refreshes daily after the close. Add Glaukos Corporation to your watchlist to track signal changes on your next visit.

Glaukos Corporation (GKOS) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

21 historical occurrences (since 2017-01-12)

Average forward return after 52-week adjusted-price high

20-day: Win 65%, Sample 20, Median +4.03%, Excess +1.74%, Beat mkt rate 60%

60-day: Win 80%, Sample 20, Median +11.47%, Excess +3.69%, Beat mkt rate 70%

120-day: Win 73.7%, Sample 19, Median +14.98%, Excess +1.8%, Beat mkt rate 63.2%

120 days after: historical avg +7.6%

20-day +3.21%
60-day +7.04%
120-day +7.6%
20-day
60-day
120-day
Win
65%
80%
73.7%
Sample
20
20
19
Median
+4.03%
+11.47%
+14.98%
Excess
+1.74%
+3.69%
+1.8%
Beat mkt rate
60%
70%
63.2%

Over 19 occurrences, 120-day forward avg gained 7.6%, beat the market by 1.8 pts; win rate 73.7%.

Top-quintile 6-month momentum

Active · now 94.99%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
27 historical occurrences (since 2016-07-14)

Average forward return after Top-quintile 6-month momentum

20-day: Win 74.1%, Sample 27, Median +8.95%, Excess +2.74%, Beat mkt rate 70.4%

60-day: Win 63%, Sample 27, Median +9.3%, Excess +2.63%, Beat mkt rate 59.3%

120-day: Win 44%, Sample 25, Median -7.01%, Excess -3.84%, Beat mkt rate 48%

120 days after: historical avg +1.49%

20-day +3.88%
60-day +6%
120-day +1.49%
20-day
60-day
120-day
Win
74.1%
63%
44%
Sample
27
27
25
Median
+8.95%
+9.3%
-7.01%
Excess
+2.74%
+2.63%
-3.84%
Beat mkt rate
70.4%
59.3%
48%

Over 25 occurrences, 120-day forward avg gained 1.49%, lagged the market by 3.84 pts; win rate 44%.

Filed revenue acceleration

Active · now 46.94%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

18 historical occurrences (since 2019-02-28)

Average forward return after Filed revenue acceleration

20-day: Win 58.8%, Sample 17, Median +3.34%, Excess -0.57%, Beat mkt rate 52.9%

60-day: Win 64.7%, Sample 17, Median +9.3%, Excess +1.26%, Beat mkt rate 58.8%

120-day: Win 43.8%, Sample 16, Median -6.23%, Excess -0.32%, Beat mkt rate 50%

120 days after: historical avg +5.82%

20-day +1.26%
60-day +5.81%
120-day +5.82%
20-day
60-day
120-day
Win
58.8%
64.7%
43.8%
Sample
17
17
16
Median
+3.34%
+9.3%
-6.23%
Excess
-0.57%
+1.26%
-0.32%
Beat mkt rate
52.9%
58.8%
50%

Over 16 occurrences, 120-day forward avg gained 5.82%, lagged the market by 0.32 pts; win rate 43.8%.

EPS surprise beat

Active · now 587.75%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest
31 historical occurrences (since 2015-11-10)

Average forward return after EPS surprise beat

20-day: Win 41.4%, Sample 29, Median -3.91%, Excess -3.25%, Beat mkt rate 31%

60-day: Win 58.6%, Sample 29, Median +9.3%, Excess +4.89%, Beat mkt rate 58.6%

120-day: Win 57.1%, Sample 28, Median +11.25%, Excess +7.94%, Beat mkt rate 57.1%

120 days after: historical avg +14.21%

20-day -1.43%
60-day +8.7%
120-day +14.21%
20-day
60-day
120-day
Win
41.4%
58.6%
57.1%
Sample
29
29
28
Median
-3.91%
+9.3%
+11.25%
Excess
-3.25%
+4.89%
+7.94%
Beat mkt rate
31%
58.6%
57.1%

Over 28 occurrences, 120-day forward avg gained 14.21%, beat the market by 7.94 pts; win rate 57.1%.

More history: Market-wide momentum baseline

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.